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Oral ulcerations are common lesions encountered in private practice. Oral ulcers can have a localised aetiology or be a mani-
festation of a variety of systemic conditions or disorders. Appropriate management depends on the correct diagnosis which can 
at times be difficult due to similar clinical features. The aetiology, diagnosis and management of the most common non-viral ul-
cerative disorders of the oral mucosa are discussed. These include traumatic ulcers, recurrent aphthous stomatitis, malignancy 
as well as oral ulceration associated with cutaneous pathology.
Introduction
Oral ulcerations are common lesions 
encountered in private practice. Oral 
ulcers can have a localised aetiology 
or be a manifestation of a variety of sys-
temic conditions or disorders (see Table 
I). Appropriate management depends 
on the correct diagnosis, which at times 
can be difficult due to similar clinical 
features. Viral infections, many of which 
present as ulcerative lesions, have been 
discussed in a previous edition.1 The 
aetiology, diagnosis and management 
of the most common non-viral ulcerative 
disorders of the oral mucosa are dis-
cussed. These include traumatic ulcers, 
recurrent aphthous stomatitis, malignan-
cy, as well as oral ulceration associated 
with cutaneous pathology.
Table I:  Classification of the more frequent 
oral ulcers based on aetiology and 
appearance
2. Persistent ulcers without vesicle 
 formation
 • Gastrointestinal disease
  Crohn’s disease
  Ulcerative colitis
 • Haematological disorders
  Leukaemia
  Neutropaenia
 • Rheumatoid Diseases
  DLE
 • Cutaneous disease
  Ulcerative lichen planus
 • Drug reactions (may be preceded 
  by vesicles)
3. Ulcers with preceding vesicle 
 formation
 • Cutaneous disease
  Mucous membrane pemphigoid
  Pemphigus vulgaris
 • Viral disease
  Herpes simplex infections
  Varicella zoster infections
  Herpangina
  Hand foot-and-mouth disease
  Measles
cally-associated ulcers is aspirin burns, 
where acetylsalicylic acid-containing 
tablets or powders are placed directly 
on the mucosa next to a carious tooth, 
resulting in various degrees of epithelial 
necrosis. Thermal burns, as seen with 
hot food, especially cheese (pizzas) and 
tomatoes, are often seen on the palate 
and tongue. Local radiotherapy and cer-
tain chemotherapy regimens can cause 
oral mucositis, which presents as multi-
ple areas of painful erythema, ulceration 
and even epithelial sloughing.2
Diagnosis
Traumatic ulcers, especially acute ul-
cers, present with various degrees of 
pain and other signs of acute inflamma-
tion. Chronic ulcers are usually painless. 
Patients are often aware of traumatic 
ulcers and can reflect the episode of 
trauma when questioned about it. These 
ulcers are usually solitary in nature.
Management
When the clinical suspicion of a trau-
matic aetiology exists for an oral ulcer, 
the cause should be determined and, 
if applicable, be removed. The patient 
should be followed up for a maximum 
of two weeks and if no clinical sign of 
improvement is present, a biopsy to 
exclude more serious possible aetiology 
is indicated. Sucking of ice at the time of 
receiving chemotherapy is effective as a 
prophylactic treatment, as it reduces the 
blood flow to the oral mucosa during the 
time of peak serum concentration. An-
tiseptic mouth washes (chlorhexidine) 
1. Solitary ulcers
 • Traumatic ulcerations
 • Malignant neoplasms
  Squamous cell carcinoma
  Extranodal non-Hodgkins lymphoma




  Deep fungal infections
2. Recurrent ulcers that heal 
 spontaneously






Acute and chronic traumatic injury to the 
oral mucosa is common and frequently 
results in ulceration. Mechanical trauma 
is the most common cause. These may 
be caused by dentures, accidental 
trauma, when soft tissue gets trapped 
between the teeth, or physiological 
trauma, where the patient has a habit of 
cheek or lip biting (morsicatio buccalis 
or labialis). It may also be iatrogenically 
induced by rotary instruments, removal 
of dried cotton rolls from the mucosa or 
negative pressure from the saliva ejec-
tor. The most common cause of chemi-
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or anti-inflammatory washes (benzyda-
mine) are often used as a treatment for 
oral mucositis in cancer patients.3
Recurrent aphthous stomatitis (RAS)
Aetiology
Recurrent aphthous stomatitis is one of 
the most common conditions leading to 
recurrent oral ulceration. The aetiology 
for RAS is basically unknown. Several 
aetiological factors, including genetic 
predisposition, local trauma, hormonal 
changes, infective agents, gastrointes-
tinal disorders, stress, immunological 
abnormalities and haematological de-
ficiencies (vitamin B12, red cell folate, 
iron), have been proposed.4 The ma-
jority of patients, however, are healthy. 
Systemic conditions, including Beçhet’s 
syndrome, and chronic malabsorption 
conditions, such as Crohn’s disease, ul-
cerative colitis and celiac disease, may 
be associated with RAS.
Diagnosis
RAS affects between 15 to 25% of the 
healthy population. Males and females 
are equally affected, with a peak in early 
adult life. It is more common in profes-
sional and semi-professional people 
and is rarely seen in smokers. The ul-
cers can arise every four to 12 weeks 
and may be classified as minor, major 
and herpetiform, affecting approxi-
mately 80%, 10% and 5 to 10% of RAS 
patients respectively. The diagnosis of 
RAS is based on the history of recur-
rences of painful, self-healing ulcers at 
regular intervals on non-keratinised mu-
cosa (labial, buccal, soft palate, ventral 
surface of the tongue, floor of mouth and 
oro-pharynx) (see Figure 1). A biopsy is 
rarely indicated. The most important 
differential diagnosis is with herpes 
simplex infection-associated ulceration 
(see Table II).5
Figure 1:  Minor aphthous ulcer (arrow) on the 



































































often only a few
Duration 7–14 days >30 days 10–30 days 5–7 days 5–7 days
Table II: Clinical features of RAS and comparison with herpes simplex ulceration
Management
About 20% of patients may have vitamin 
B12, red cell folate or iron deficiency, 
and it is therefore best to exclude these 
potential causes. These conditions are 
No treatment
Reassure the patient that:
•  It’s a common condition, it’s not malignant, it has no 
malignant potential and it’s not contagious or infec-
tious
Self-medication:
• Covering agents like orabase
• Antiseptic mouthwashes (Corsodyl, Chlorhexidine) 
Avoid sharp and spicy foods and acidic or carbonated 
drinks
Mild ulceration (ulcer-free 
period of one month or more)
Kenalog in orabase (triamcinolone) 
• Apply to dried ulcer with ear bud or moistened finger. 
•  Allow to become wet before contact with uninvolved 
mucosa. Four times daily, one application before go-
ing to bed. For use where ulcers are accessible
Moderately severe ulcer-
ation (2–4 week ulcer-free 
period)
Betamethasone mouthwash (Celestone 0.5 mg tab in 
5–10 ml warmish water)
•  Four times daily. Hold in mouth for 3 min and spit out 
Prednisone mouthwash (Meticorten 5 mg in 15 ml warm-
ish water)
•  Four times daily. Hold in mouth for 3 min and spit out. 
It may also be applied to a small piece of cotton wool 
and this held over the lesion for longer
0.05% Fluocinonide in orabase (50/50)
• Applied 6x pd to early ulcers
Beclomethasone dipropionate aerosol (Beconase spray)
2 puffs (100 microgram) onto affected area. Maximum of 
8 puffs/day
Severe ulceration (ulcer-free 
less than two weeks, all major 
RAS)
Systemic corticosteroids
•  30–60 mg daily for a week, followed by a one-week 
taper
Thalidomide (50–200 mg daily for four to eight weeks) 
has been used successfully in selected cases, but is 
rarely indicated due to severe side effects 
Referral is indicated
Herpetiforme RAS
Tetracycline 250 mg caps dissolved in 10 ml of warm-
ish water as mouthwash
•  Hold in mouth for 3 min and then spit out. Three times 





Ensure eating and hydration (parents)
Local anaesthetic preparation on ulcer before eating 
More severe – Kenalog in orabase (children may need 
help with application)
Table III: Treatment options for RAS
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more likely to be present in older pa-
tients whose ulceration starts or worsens 
in middle age. Correcting the deficiency 
has been shown to bring rapid relief 
for these patients. Treatment is mostly 
symptomatic, aimed mainly at pain re-
lief, reducing the frequency of ulceration 
and preventing secondary infection. 
The choice of therapy depends on the 
severity and frequency of ulceration 
(see Table III). 
Malignant ulcers
Aetiology
A range of malignant neoplasms may 
present as an ulcerative lesion, of which 
oral squamous cell carcinoma is by far 
the most common. Oral cancer is a life-
threatening disease in most countries, 
especially in developing countries. The 
severity of oral cancer in South Africa is 
demonstrated by the fact that it is one of 
the most common malignancies in South 
African males, a fact that is not often ap-
preciated.6 One of the reasons may be 
that oral cancer is not registered as a 
single entity in the local cancer registry, 
but separated into cancers originating 
from the mouth, tongue or gums. Oral 
cancer is largely a preventable disease, 
as the primary aetiological agents are 
tobacco products, heavy use of alcohol, 
and especially the combination of these 
two.7 More than 90% of oral cancer pa-
tients give a history of tobacco use. All 
forms of tobacco use are implicated, 
including smokeless tobacco (chewing 
tobacco and snuff dipping).8
Diagnosis
Early detection of oral cancer allows 
for a five-year survival rate of close to 
90%. However, most oral cancers are 
diagnosed at an advanced stage, with 
a five-year survival rate of about 20%, 
which is one of the worst prognoses of 
all major cancers. This is a tragic situa-
tion because no specialised techniques 
are required to examine the oral cavity 
for the presence of precursor lesions or 
early oral cancers. Prevention and early 
diagnosis are therefore of the utmost 
importance. 
Early cancerous lesions are usually 
painless and may appear as small, ap-
parently harmless areas of induration, 
erosion or keratosis, often deceiving 
the unsuspecting clinician into a false 
sense of security. The advanced oral 
cancerous lesion usually consists of a 
persistent painless ulcer with indurated, 
rolled margins. In most cases the ulcer 
has a characteristic appearance that 
may serve as a diagnostic aid (see Fig-
ure 2). It may be fixed to underlying soft 
tissues and bone, and regional lymph-
adenopathy may be present. Malignant 
ulcers are usually painless unless sec-
ondarily infected. In advanced cases, 
patients may present with trismus or 
impaired tongue movement. Cancers 
of the tongue may also present with ear 
pain due to involvement of n. glossopha-
ryngeus.
Figure 2:  Squamous cell carcinoma present-
ing as an indurated ulcer (arrow) 
on the lateral border of the tongue.
Management
Any suspicious-looking oral mucosal 
lesion, including any ulcer not healing 
within two weeks after conservative 
treatment, must be biopsied to estab-
lish the diagnosis. The biopsy should 
be sufficiently large to include enough 
abnormal and clinically normal tissue, 
enabling the pathologist to make a diag-
nosis without requesting additional ma-
terial. After the diagnosis of oral cancer 
has been confirmed, the patient should 
be referred to a head and neck surgeon 
for further management and treatment, 
which may vary from a localised exci-
sion to extensive surgery with adjuvant 
chemo- and radiotherapy. 
Cutaneous disease
Aetiology
Ulcers may be a manifestation of several 
skin diseases, the most common being 
lichen planus, pemphigus vulgaris 
erythema multiforme and mucous mem-
brane pemphigoid.
Diagnosis
Lichen planus (LP) is a chronic muco-
cutaneous disease in which skin and 
oral lesions are seen simultaneously in 
almost 40% of patients. Isolated skin 
(35%) and mucosal (25%) lesions may 
also be seen. LP presents with three dis-
tinct clinical patterns: reticular, erosive 
and plaques.9 It is common for patients 
to have a mixture of these three pat-
terns. Reticular LP is the most common 
form and consists of bilateral, raised, 
delicate thin white lines that produce 
a lace-like pattern set on an erythema-
tous background. These lesions are 
commonly seen on the buccal mucosa 
and are usually asymptomatic. Erosive 
LP presents with atrophic and erosive 
areas on an erythematous background. 
Faint white striae can often be identified 
at the margin of the ulcers (see Figure 
3). These lesions are painful and may 
be difficult to differentiate clinically from 
other erosive oral conditions, such as 
mucous membrane pemphigoid and 
pemphigus vulgaris. Plaque LP pres-
ents as white, flat to slightly raised ar-
eas, indistinguishable from leukoplakia. 
It is most commonly seen on the tongue. 
Patients may have other features of 
lichen planus in the mouth that may help 
to differentiate this lesion. It is usually 
asymptomatic. The clinical picture of LP 
is often characteristic, but the diagnosis 
should always be confirmed with an in-
cisional biopsy.
Figure 3:  Lichen planus presenting with 
white striae (arrow) on the buccal 
mucosa that are combined with 
erosive red areas of ulceration 
(asterisk).
Pemphigus vulgaris (PV) is an autoim-
mune disease characterised by an 
antigenic attack and destruction of the 
desmosomal attachment (intracellular 
cohesive system) of epithelial cells. This 
results in epithelial separation above the 
basal cell layer, causing bullae on the 
skin and mucosae.10 The oral lesions 
precede cutaneous involvement in 75% 
of affected patients. Although lesions 
may be confined to the oral cavity, the 
skin lesions usually develop in the sub-
sequent months. Failure to recognise 
the early oral lesion leads to a substan-
tial delay in the diagnosis of this serious 
and life-threatening systemic disorder. 
Large and painful oral ulcerations are 
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most commonly seen. Although these 
lesions start as bullae, they are soon lost 
due to trauma during normal mastica-
tion. All mucosal surfaces may be af-
fected, but the soft palate is most com-
monly involved, followed in order of fre-
quency by the buccal mucosa, tongue 
and gingiva (see Figure 4). The use of a 
blunt instrument will cause the epithelial 
tissue to form a bulla and to separate, 
in both the skin and oral mucosa. This 
is called the Nikolsky sign. Although this 
sign is seen in other desquamative con-
ditions, it is more commonly seen in PV. 
The diagnosis should be confirmed with 
an incisional biopsy of an intact bulla, 
with inclusion of the adjacent normal 
mucosa in order to evaluate the transi-
tional zone.
Figure 4:  Ulcerations with surrounding ery-
thema on the buccal mucosa (ar-
rows) in a patient with pemphigus 
vulgaris.
Erythema multiforme (EM) is an inflam-
matory disease of immune origin affect-
ing the skin and mucosa. It arises due 
to immune complexes binding to vessel 
walls, with a subsequent inflammatory 
process that leads to tissue loss. The 
specific aetiology in a given patient is 
often unknown, although herpes sim-
plex virus and certain drugs may be in-
volved. EM is characterised by the rapid 
onset of oral, cutaneous and ocular 
lesions. The skin lesions are discrete, a-
symptomatic, erythematous macules or 
sometimes vesicles that are distributed 
in a symmetrical manner on the hands, 
arms, legs, face and neck. These le-
sions are known as bull’s-eye or target 
lesions, appearing as a concentric 
erythematous patch with a peripheral 
thin pale zone and a surrounding larger 
erythematous zone (Figure 5). The cen-
tral small papule or bulla soon ruptures, 
but heals rapidly, often leaving the red 
zone behind for a longer period. Skin 
lesions are pathognomic for EM. Oral 
lesions are seen in 30 to 60% of cases, 
and may be confined to the oral cavity. 
The oral lesions are areas of painful ery-
thema, bullae and ulcers, as well as ar-
eas of bleeding and crusting (Figure 6). 
The buccal mucosa, lips, soft palate and 
tongue are the most commonly involved 
sites. The clinical course of erythema 
multiforme is usually over a period of 
three to four weeks. Recurrences are 
common, usually at intervals of several 
months over a period of years. Progres-
sion to more severe forms of EM (Steven 
Johnson Syndrome and toxic epidermal 
necrolysis) sometimes occurs, with ex-
tensive systemic involvement. 
Figure 5:  Characteristic target lesions (ar-
rows) of erythema multiforme on 
the dorsum of the hand.
Figure 6:  Extensive ulceration and charac-
teristic crust formation (arrow) on 
the lips of the same patient with 
erythema multiforme
Mucous membrane pemphigoid (MMP) 
is an autoimmune disease most com-
monly seen in middle-aged to older 
females. It is characterised by bullous 
eruptions and ulceration, particularly 
of the oral mucosa and conjunctiva.11 
Eighty percent of the affected patients 
have oral lesions in the form of shallow 
ulcerations and a characteristic form of 
gingivitis known as desquamative gin-
givitis (see Figure 7). Seventy percent 
may have conjunctival lesions, 25% 
have genital lesions, and 20% have skin 
lesions. Involvement of the eye conjunc-
tiva is a major concern. Bullae, erosions 
and generalised swelling and erythema 
can lead to the formation of adhesive 
tissue bands extending from the conjun-
tiva of the eye to the sclera, and this can 
result in entropion and blindness. 
Figure 7:  MMP presenting as desquama-
tive gingivitis of the gingival, with 
resulting ulceration (arrows).
Management
As LP is a chronic disease with no cure, 
treatment is aimed at symptomatic con-
trol. If the patient is asymptomatic, no 
active treatment is required. For symp-
tomatic atrophic or erosive lesions, treat-
ment consists of topical steroids such as 
fluocinonide gel (0.05%) applied four to 
six times a day (mix with Orabase 1:1 
to facilitate adhesion). Topical therapy 
affords only temporary control of the 
disease and patients should be advised 
that the lesions might recur. The devel-
opment of iatrogenic candidiasis should 
be monitored and managed. 
Patients with PV should be referred 
for specialist treatment. Prolonged high 
dosages of systemic corticosteroids 
that are tapered as soon as control is 
obtained are still the mainstay of treat-
ment. Secondary infection of the ulcer-
ated areas should be monitored and 
managed. 
The aetiological factor in EM should 
be eliminated if applicable. Mild cases 
of EM require only symptomatic treat-
ment, which may include analgesics 
and anti-inflammatories such as aspi-
rin or non-steroidal anti-inflammatory 
drugs. However, care should be taken 
to check the history to ensure the EM 
was not precipitated by NSAIDs. Topi-
cal steroids can also be prescribed. 
Minimising mucosal damage by means 
of a bland liquid diet is essential. Main-
taining optimal oral hygiene to prevent 
secondary infections with agents such 
as Candida is also important.
Treatment for MMP is similar to that 
of pemphigus vulgaris. Topical cortico-
steroids (fluocinonide gel 0.05%, mixed 
with Orabase) are indicated, especially 
for gingival lesions. Systemic cortico-
steroids are indicated in severe cases. 
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Oral hygiene may be difficult for the pa-
tient, given the desquamative gingivitis. 
Mouth washes containing agents such 
as chlorhexidine are beneficial. Oph-
thalmologic examination is important to 
evaluate and exclude the possibility of 
early ocular disease. Patients should 
also be made aware of this in order to 
facilitate long-term management.
Conclusion
All patients with recurrent or persistent 
oral ulceration should be fully inves-
tigated to establish a definitive diag-
nosis and to eliminate the possibility 
of an underlying systemic disorder or 
oral malignancy. Ulcers should always 
be examined for induration or fixation, 
which may be indicative of malignancy. 
Unless the cause is undoubtedly local, 
general physical examination is always 
indicated, looking especially for mu-
cocutaneous lesions or other systemic 
conditions. All undiagnosed ulcers, as 
well as ulcers that are suspected as 
being malignant, should be biopsied. 
Although oral ulceration therefore may 
pose a clinical dilemma, thorough clini-
copathological examination will usually 
result in a final diagnosis that can lead 
to optimal management and treatment 
of such a patient.  
See CPD Questionnaire, page 42
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